TRIUMF Enters Collaboration with Fusion Pharmaceuticals to Boost Production of Actinium-225, a ...

Retrieved on: 2020-12-16 14:03:45

Tags for this article:

Physical sciences

Natural sciences

Targeted alpha-particle therapy

Astatine

Radon

TRIUMF Innovations

Fusion Pharmaceuticals Inc.

Canada

Click the tags to see associated articles and topics

TRIUMF Enters Collaboration with Fusion Pharmaceuticals to Boost Production of Actinium-225, a .... View article details on hiswai: https://financialpost.com/pmn/press-releases-pmn/globe-newswire-releases/triumf-enters-collaboration-with-fusion-pharmaceuticals-to-boost-production-of-actinium-225-a-cancer-fighting-medical-isotope

Excerpt

<b>VANCOUVER</b>, British Columbia, Dec. 16, 2020 (GLOBE NEWSWIRE) — TRIUMF, Canada's particle accelerator centre, today announced <b>it</b> has ...

Article found on: financialpost.com

View Original Article